October 30, 2020
This past week, two public companies settled their dispute over the ownership of a Canadian cannabis producer.
October 8, 2020
INN chatted with IntelGenx, whose technology could help psychedelics companies with their research in the growing space.
January 15, 2020
Health Canada has issued a No Objection Letter in response to IntelGenx’s amended application for its ongoing trial in patients...
January 13, 2020
IntelGenx confirmed that its cannabis-infused oral film, VersaFilm, is on track to be released commercially in Q1 2020.
October 9, 2019
The Data Safety Monitoring Board completed its analysis of the company's Montelukast VersaFilm Phase 2a clinical trial of Alzheimer's Disease.
September 4, 2019
One pharmaceutical company is giving consumers the chance to experience the effects of cannabis in a new form: oral strips.
May 8, 2019
IntelGenx (TSXV:IGX, OTCQX:IGXT) has announced it has entered into a partnership with Aquestive Therapeutics (NASDAQ:AQST) to co-develop and commercialize Tadalafil...